-+ 0.00%
-+ 0.00%
-+ 0.00%

SELLAS LIFE SCIENCES PROVIDES UPDATE ON PIVOTAL PHASE 3 REGAL TRIAL OF GALINPEPIMUT-S (GPS) IN ACUTE MYELOID LEUKEMIA (AML)

路透·12/29/2025 13:35:00

登錄查看新聞詳情